Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase Ib |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase IB clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00-VP, adminstered at 2 different dosing schedules, in HIV-1-uninfected adult participants
Description
HVTN 052 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of VRC-HIVDNA009-00-VP (DNA) adminstered at 2 different dosing schedules.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.